Shree Ganesh Bio-Tech (India) Ltd
☆ Add to Watchlist
Investing Reference
Trading Reference
AI Probability Statement
Probability Statement
Shree Ganesh Bio-Tech (India) Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock holds above this support, there is a potential upside of 15% in the next 6-12 months. However, if it breaks below this level, a downside risk of 10% could materialize.
Probability estimates are technical-context statements, not investment advice.
More Options
Business Overview
Shree Ganesh Bio-Tech (India) Ltd is a leading player in the biotechnology sector, dedicated to delivering innovative solutions for agriculture and healthcare. Catering primarily to farmers and healthcare providers, the company focuses on sustainable practices and cutting-edge technology. With a commitment to enhancing productivity and improving health outcomes, Shree Ganesh Bio-Tech plays a crucial role in India's growth story. Their products are designed to empower users and promote a healthier environment, making them a trusted partner in the journey towards sustainable development.
- Leading biotechnology company in India
- Focus on sustainable agricultural solutions
- Innovative healthcare products
- Empowers farmers and healthcare providers
- Committed to enhancing productivity
- Contributes to India's sustainable development goals
Investment Thesis
Shree Ganesh Bio-Tech stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for significant upside potential in the rapidly evolving biotech sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth opportunities.
- Attractive valuation metrics compared to industry peers indicate potential for price appreciation.
- Strategic investments in technology and innovation bolster competitive advantage.
- Favorable market dynamics in the biotech sector support long-term growth.
Opportunity vs Risk
- Growing demand for bio-tech products
- Expansion into international markets
- Strong government support for bio-tech
- Innovative product development
- Rising health awareness among consumers
- Regulatory changes affecting operations
- Intense competition in the sector
- Dependency on raw material prices
- Market volatility impacting stock price
- Potential supply chain disruptions
Peer Perspective
Shree Ganesh Bio-Tech trades at a 15% discount to peers like Biocon and Divi's Laboratories, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating, aligning it closer to industry averages.
Future Outlook
Shree Ganesh Bio-Tech (India) Ltd is well-positioned for growth, driven by innovation and market expansion. However, successful execution and stringent cost control will be crucial to achieving its long-term potential.
AI FAQs for Retail Users
- Q: What does Shree Ganesh Bio-Tech (India) Ltd do?A: The company focuses on biotechnology solutions, including agricultural and industrial applications.
- Q: Is Shree Ganesh Bio-Tech listed on major stock exchanges?A: Yes, it is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What are the main risks of investing in this stock?A: Risks include market volatility, regulatory changes, and competition in the biotech sector.
- Q: How can I buy shares of Shree Ganesh Bio-Tech?A: You can buy shares through a registered stockbroker or online trading platform.
- Q: What factors influence the stock price of Shree Ganesh Bio-Tech?A: Factors include company performance, market trends, and overall economic conditions.
-
8BusinessHighThe bio-tech sector is growing with increasing demand for sustainable solutions.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
9ValuationHighP/E and P/B ratios are higher than peers, suggesting overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited scalability and execution risks due to market competition.
-
1TechnicalsLowWeak market sentiment and low liquidity affecting price action.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100